Form D · Biotechnology
Third Eye Diagnostics Inc
Bethlehem, PA · CIK 0001650881
Offering snapshot reported Aug 17, 2015 · SEC filing
- Reported sold
- $250K Offering amount: $3M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jul 31, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2015 | Initial | $250,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-245902
Conversion of 2 convertible notes ancillary to offering. Warrants will be issued to converter of debt.
Source: Form D, filed Aug 17, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony J Bellezza | Director, Executive |
| Terry A Fuller | Director, Executive |
| William Lai | Executive |
| Albert Davis Woodward | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
116 Research Drive
Bethlehem, PA, 18015
Bethlehem, PA, 18015